Atyr Pharma, Stock Price on December 1, 2024
| ATYR Stock | 3.53 0.09 2.62% |
Below is the normalized historical share price chart for aTyr Pharma, extending back to May 07, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ATyr Pharma, stands at 3.53, as last reported on the 1st of December, with the highest price reaching 3.56 and the lowest price hitting 3.32 during the day.
If you're considering investing in ATyr Stock, it is important to understand the factors that can impact its price. ATyr Pharma, is slightly risky given 3 months investment horizon. aTyr Pharma, secures Sharpe Ratio (or Efficiency) of 0.25, which signifies that the company had a 0.25% return per unit of risk over the last 3 months. We have analyzed and interpolated thirty different technical indicators, which can help you to evaluate if expected returns of 1.18% are justified by taking the suggested risk. Use ATyr Pharma, Downside Deviation of 3.47, risk adjusted performance of 0.1849, and Semi Deviation of 2.69 to evaluate company specific risk that cannot be diversified away.
As of 12/01/2024, Stock Based Compensation To Revenue is likely to grow to 7.73, while Total Stockholder Equity is likely to drop slightly above 83.3 M. . At this time, ATyr Pharma,'s Price To Sales Ratio is relatively stable compared to the past year. As of 12/01/2024, Price Book Value Ratio is likely to grow to 1.07, while Price Earnings To Growth Ratio is likely to drop 0.02. ATyr Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of May 2015 | 200 Day MA 1.7116 | 50 Day MA 1.841 | Beta 1.214 |
ATyr |
Sharpe Ratio = 0.25
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATYR | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.72 actual daily | 42 58% of assets are more volatile |
Expected Return
| 1.18 actual daily | 23 77% of assets have higher returns |
Risk-Adjusted Return
| 0.25 actual daily | 19 81% of assets perform better |
Based on monthly moving average ATyr Pharma, is performing at about 19% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ATyr Pharma, by adding it to a well-diversified portfolio.
Price Book 1.7647 | Enterprise Value Ebitda (0.81) | Price Sales 244.9197 | Shares Float 73.8 M | Wall Street Target Price 22 |
ATyr Pharma, Valuation on December 1, 2024
It is possible to determine the worth of ATyr Pharma, on a given historical date. On December 1, 2024 ATyr was worth 3.44 at the beginning of the trading date compared to the closed value of 3.53. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ATyr Pharma, stock. Still, in general, we apply an absolute valuation method to find ATyr Pharma,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ATyr Pharma, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ATyr Pharma,'s related companies.
| Open | High | Low | Close | Volume | |
| 3.44 | 3.56 | 3.32 | 3.53 | 543,500 | |
12/01/2024 | 3.44 | 3.56 | 3.32 | 3.53 | 0.00 |
| Backtest ATyr Pharma, | | | ATyr Pharma, History | | | ATyr Pharma, Valuation | Previous |
ATyr Pharma, Trading Date Momentum on December 1, 2024
| On December 01 2024 aTyr Pharma, was traded for 3.53 at the closing time. The top price for the day was 3.56 and the lowest listed price was 3.32 . There was no trading activity during the period 0.0. Lack of trading volume on December 1, 2024 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 2.55% . |
aTyr Pharma, Fundamentals Correlations and Trends
By evaluating ATyr Pharma,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ATyr Pharma,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ATyr financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ATyr Pharma, Stock history
ATyr Pharma, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ATyr is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in aTyr Pharma, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ATyr Pharma, stock prices may prove useful in developing a viable investing in ATyr Pharma,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 53.6 M | 30.3 M |
ATyr Pharma, Quarterly Net Working Capital |
|
ATyr Pharma, Stock Technical Analysis
ATyr Pharma, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ATyr Pharma, Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
aTyr Pharma, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ATyr Pharma, December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how ATyr Pharma, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ATyr Pharma, shares will generate the highest return on investment. By undertsting and applying ATyr Pharma, stock market strength indicators, traders can identify aTyr Pharma, entry and exit signals to maximize returns
ATyr Pharma, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ATyr Pharma,'s price direction in advance. Along with the technical and fundamental analysis of ATyr Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ATyr to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1849 | |||
| Jensen Alpha | 0.984 | |||
| Total Risk Alpha | 0.2913 | |||
| Sortino Ratio | 0.2736 | |||
| Treynor Ratio | 1.47 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ATyr Stock Analysis
When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.